Pfizer Delves Deeper In Generics Partnership With Strides Arcolab

NEW DELHI - Pfizer has further expanded its generic drug portfolio by signing two more license and supply agreements with Strides Arcolab, just four months after Pfizer partnered with the Bangalore-based drug manufacturer to bring generic injectable and oral drugs to the U.S. market